Sarah Wakeman, MD

Dr. Sarah Wakeman is medical director of the Substance Use Disorder Initiative and the Addiction Consult Team at Massachusetts General Hospital (MGH), co-chair of the Mass General Opioid Task Force, and clinical lead for the Partners Healthcare Substance Use Disorder Initiative. Dr. Wakeman is also Assistant Professor in Medicine at Harvard Medical School.

Dr. Wakeman received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and a fellow of the American Board of Addiction Medicine.

Dr. Wakeman’s clinical interest and expertise is in the care of patients with addiction within general medical settings. Clinically, she provides primary care and office-based addiction care, as well as inpatient specialty consultation for addiction. She teaches locally, regionally, and nationally about addiction and has led workshops and delivered invited symposia at national conferences. She was appointed by Governor Baker to serve on his Opioid Addiction working group. She serves as secretary for the Massachusetts Society of Addiction Medicine (MASAM) and chair of the MASAM policy committee.

In addition to providing clinical care and teaching, she conducts research on physician preparedness and attitudes related to addiction. She has studied the quality of training resident physicians receive in addiction medicine. She has ongoing research evaluating the impact of the addiction consultation on addiction severity, health care costs and utilization. She has published perspectives, reviewes, and research articles in leading peer reviewed journals, including The New England Journal of Medicine, The Journal of the American Medical Association, The Journal of General Internal Medicine The American Journal of Medicine, Substance Abuse and others.

Back to Top